高级检索
当前位置: 首页 > 详情页

Pharmacologic Treatment of Restless Legs Syndrome

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurology, TongRen Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China [2]Department of Neurosurgery, Hamamatsu University School of Medicine, Handayama, 1-20-1, Higashi-ku, Hamamatsucity, Shizuoka 431-3192, Japan [3]Research Base of Traditional Chinese Medicine Syndrome, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
出处:
ISSN:

关键词: Restless legs syndrome dopaminergic drugs nondopaminergic drugs mechanisms genetic factors augmentation

摘要:
Restless legs syndrome (RLS)/Willis-Ekbom disease is a neurologic disorder characterized by a strong desire to move when at rest (usually in the evening) and paraesthesia in their lower legs. The most widely used therapies for first-line treatment of RLS are dopaminergic drugs; however, their long-term use can lead to augmentation. a2d Ligands, opioids, iron, glutamatergic drugs, adenosine, and sleep aids have been investigated as alternatives. The pathogenesis of RLS is not well understood. Despite the efficacy of dopaminergic drugs in the treatment of this disorder, unlike in Parkinson's disease dopaminergic cell loss in the substantia nigra has not been observed in RLS. The etiology of RLS is likely complex, involving multiple neural pathways. RLS-related genes identified in genome-wide association studies can provide insight into the mechanistic basis and pathophysiology of RLS. Here we review the current treatments and knowledge of the mechanisms underlying RLS.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版
大类 | 2 区 医学
小类 | 2 区 药学 3 区 神经科学
最新[2025]版
大类 | 3 区 医学
小类 | 2 区 药学 3 区 神经科学
JCR分区:
出版当年[2019]版:
Q1 PHARMACOLOGY & PHARMACY Q1 NEUROSCIENCES
最新[2024]版:
Q1 NEUROSCIENCES Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of Neurology, TongRen Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China
通讯作者:
通讯机构: [1]Department of Neurology, TongRen Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China [2]Department of Neurosurgery, Hamamatsu University School of Medicine, Handayama, 1-20-1, Higashi-ku, Hamamatsucity, Shizuoka 431-3192, Japan [3]Research Base of Traditional Chinese Medicine Syndrome, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China [*1]Department of Neurology, TongRen Hospital, Shanghai Jiao Tong University School of Medicine, No.1111 Xianxia Road, 200336, Shanghai, China [*2]Department of Neurosurgery, Hamamatsu University School of Medicine, Handayama, 1-20-1, Higashi-ku, Hamamatsu-city, Shizuoka 431-3192, Japan
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:29059 今日访问量:0 总访问量:1619 更新日期:2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)